Skip to content
media1

Zprávy skupiny

  • Aspen’s revenue increases 10% underpinned by a strong second half performance
    on 03.09.2024

    JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has reported solid Group financial results for the year ended 30 June 2024. The post Aspen’s revenue increases 10% underpinned by a strong second half performance appeared first on Aspen Pharmacare.

  • Aspen’s Mandela Day programme changes more than 910 000 lives over 14 years
    on 17.07.2024

    Durban – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded pharmaceutical company, is celebrating its 14th consecutive year of Group-wide participation in Mandela Day.   Stephen Saad, Aspen Group Chief Executive said, “ Aspen has a track record of improving access to healthcare to all patients but more particularly the… Continue reading Aspen’s Mandela Day programme changes more than 910 000 lives over 14 years The post Aspen’s Mandela Day programme changes more than 910 000 lives over 14 years appeared first on Aspen Pharmacare.

  • Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships
    on 06.05.2024

    Johannesburg, South Africa – Aspen Pharmacare Holdings Limited (“Aspen”), a global multinational specialty pharmaceutical company, has presented a state-of-the-art high performance wheelchair to South African wheelchair tennis star Donald Ramphadi.   Ramphadi, a French-open double quads champion and a prominent figure in wheelchair tennis, reached his maiden Grand Slam final at the Australian Open Wheelchair… Continue reading Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships The post Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships appeared first on Aspen Pharmacare.

  • Aspen announces additional pharmaceutical donations for Ukranian patients
    on 25.03.2024

      Johannesburg, South Africa – Aspen Pharmacare, Africa’s largest pharmaceutical company, has announced continued humanitarian support to Ukraine, confirming further donations of critical care products to treat hospitalized patients who have been impacted by the ongoing conflict in that country.   Stavros Nicolaou, Aspen Group Senior Executive Strategic Trade, said, “Aspen is highly sensitised to… Continue reading Aspen announces additional pharmaceutical donations for Ukranian patients The post Aspen announces additional pharmaceutical donations for Ukranian patients appeared first on Aspen Pharmacare.

  • Aspen building momentum with revenue up 10% to R21,1 billion
    on 04.03.2024

    Johannesburg – JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has reported solid unaudited interim Group financial results for the six months ended 31 December 2023. SALIENT HIGHLIGHTS Revenue increased by 10% (2% in constant exchange rate (“CER”)) to R21,1 billion (December 2022: R19,2 billion) Normalised EBITDA increased by 2% (-5%… Continue reading Aspen building momentum with revenue up 10% to R21,1 billion The post Aspen building momentum with revenue up 10% to R21,1 billion appeared first on Aspen Pharmacare.

Scroll To Top